Genstar Capital has acquired Bracket, a provider of clinical trial technology and other specialty services, from Parthenon Capital Partners. Parthenon acquired Bracket in August 2013 from publicly-traded Express Scripts. Bracket’s services are used by pharmaceutical companies and contract research organizations to maximize the integrity of clinical data in order to achieve greater certainty in clinical trial…...
